Amorphous or Crystalline? A Comparison of Particle Engineering Methods and Selection

Area of Science:

• Pharmaceutical Technology
• Materials Science
• Chemical Engineering

Background:

• Particle engineering is crucial for controlling drug properties.
• Crystalline and amorphous forms offer distinct formulation advantages.
• Current technologies require critical evaluation for optimal production.

Purpose of the Study:

• To provide a critical review of particle engineering technologies.
• To discuss methods for producing crystalline and amorphous particles.
• To assess the impact of particle properties on bioavailability.

Main Methods:

• Review of traditional crystallization, supercritical fluid, spray drying, controlled solvent crystallization, and sonocrystallization.
• Presentation of advanced techniques: spray freezing into liquid, thin-film freeze-drying, and PRINT technology.
• Examination of characterization methods and their limitations.

Main Results:

• Detailed comparison of various particle engineering technologies.
• Analysis of the merits and limitations of each method.
• Discussion on the role of particle engineering in enhancing bioavailability.

Conclusions:

• Particle engineering offers diverse strategies for crystalline and amorphous particle production.
• Selection of appropriate technology depends on desired particle properties and formulation goals.
• Understanding technology limitations and characterization is key for successful drug development.